Genoway SA
PAR:ALGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Genoway SA
PAR:ALGEN
|
FR |
|
Federal Corp
TWSE:2102
|
TW |
|
E
|
Ethos Ltd
BSE:543532
|
IN |
|
Mirbud SA
F:9SX
|
PL |
|
AGCO Corp
NYSE:AGCO
|
US |
|
Banco Santander SA
MAD:SAN
|
ES |
|
M
|
MadUp Inc
KOSDAQ:0039P0
|
KR |
|
Domo Inc
NASDAQ:DOMO
|
US |
|
I
|
ING Groep NV
SWB:INNA
|
NL |
|
R
|
Restaurant Brands International Inc
SWB:0R6
|
US |
|
Lu-Ve SpA
MIL:LUVE
|
IT |
|
C
|
Cowealth Medical Holding Co Ltd
TPEX:4745
|
KY |
|
E
|
Element Fleet Management Corp
OTC:ELEEF
|
CA |
|
Airbus SE
MIL:1AIR
|
NL |
|
O
|
Orvana Minerals Corp
OTC:ORVMF
|
CA |
|
Stora Enso Oyj
F:ENUS
|
FI |
|
LATAM Airlines Group SA
NYSE:LTM
|
CL |
|
Digital Core REIT
SGX:DCRU
|
SG |
|
Miramar Resources Ltd
ASX:M2R
|
AU |
|
S
|
S V Global Mill Ltd
BSE:535621
|
IN |
|
Procter & Gamble Co
NYSE:PG
|
US |
|
R
|
RF Materials Co Ltd
KOSDAQ:327260
|
KR |
Bankruptcy Probability
Genoway SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Genoway SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Genoway SA
PAR:ALGEN
|
27m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Genoway SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Genoway SA has total debt of 12.5m EUR. This includes both short-term (7.5k EUR) and long-term (12.5m EUR) debt.
You can find a full breakdown on its Balance Sheet.